A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis
Theresa Perney
Nature Medicine, Published online: 28 April 2026; doi:10.1038/s41591-026-04267-z A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis